Clinical Trial Update: A/H1N1 Immunogenicity and Safety in Adults [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial completed evaluating the immunogenicity and safety of an A/H1N1 influenza vaccine candidate in adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pandemic Influenza

Snippet

Sponsor: Alachua Government Services, Inc. | Conditions: Influenza, Pandemic Influenza | Phase 1, Phase 2 | Status: COMPLETED